Pharmacoepidemiology and Drug Safety

Papers
(The H4-Index of Pharmacoepidemiology and Drug Safety is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
100
Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second‐Line Treatment of Advanced Non–Small Cell Lung Cancer86
Issue Information74
Quantitative Benefit–Risk Assessment of Vaccination Against COVID‐19: A Systematic Review60
Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries53
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data48
Causal Forests Versus Inverse Probability of Treatment Weighting to Adjust for Cluster‐Level Confounding: A Parametric and Plasmode Simulation Study Based on US 46
External validity in distributed data networks44
Correction to “Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using 44
Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review42
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark41
All Lines Is the Right Approach: Selecting Patient Lines of Therapy for an External Comparator Arm39
Letter to the Editor34
Methodological Characteristics in Economic Evaluations of Health Technology Assessment Reports Submitted for Drug Reimbursement in Brazilian Public Health32
Beta Blocker Use and Total Knee Arthroplasty Among United States Medicare Beneficiaries30
Warfarin‐Associated Bleeding and Thromboembolic Events in Sub‐Saharan Africa: A Systematic Review and Meta‐Analysis29
Validation of diagnosis codes for chorioamnionitis in medical encounter data, 2013–201829
Development and Validation of an Endometrial Cancer Algorithm in US Claims Data28
Issue Information28
Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate (ETIE)—A Framework of Diversity and Fairness in Pharmacoepidemiologic Research24
Data Resource Profile: The Danish National Hospital Medicine Register23
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+23
ORAL PRESENTATION23
0.24347519874573